Medical Condition News

RSS

Scientists make breakthrough in developing new treatment for advanced bladder cancer

Scientists from Queen Mary University of London have made a breakthrough in developing a new therapy for advanced bladder cancer - for which there have been no major treatment advances in the past 30 years.

26 Nov 2014

Researchers set up innovative project to monitor physical activity of patients with haemophilia

The research group Intelligent Data Analysis Laboratory from the School of Engineering Universitat de València (UV) and a team of scientists at the Faculty of Physiotherapy led by Professor Felipe Querol have set up an innovative project for monitoring the physical activity of people with haemophilia through individual devices with the purpose of developing patterns which help to improve their quality of life and treatments.

26 Nov 2014

BWH researchers identify two-faced role of TIM-3 protein

A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system -- sometimes dampening it, other times stimulating it. This newly identified partner not only sheds light on the inner workings of the immune system in diseases such as HIV, autoimmunity, and cancer, but also provides a critical path toward the development of novel treatments that target TIM-3.

26 Nov 2014

National Spine & Pain Centers opens new pain management center in Cumberland, Maryland

Over 100 million adults suffer from chronic pain and about half of those suffer from this pain daily. Chronic and acute pain dramatically impacts quality of life. The specialty of pain management is born to fulfill the need for non-surgical, interventional solutions and medication management to treat all types of pain.

26 Nov 2014

Researchers demonstrate efficacy of Bozepinib drug against cancerogenic stem cells

An Andalusian team of researchers led by the University of Granada has demonstrated the efficacy of a new drug against cancerogenic stem cells, which cause the onset and development of cancer, of relapse after chemotherapy and metastasis. This drug, called Bozepinib, has proved to be effective in tests with mice.

26 Nov 2014

Quarter of all obesity-related cancers in 2012 attributed to increasing BMI, say researchers

Based on the results, the researchers led by Dr Melina Arnold from the International Agency for Research on Cancer, estimate that a quarter of all obesity-related cancers in 2012 (118 000 cases) were attributable to the rising average body mass index (BMI) in the population since 1982, and were therefore "realistically avoidable".

26 Nov 2014

Presence of certain proteins in HDL can lead to cardiovascular risk

A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.

26 Nov 2014

Orgenesis receives €2.015 million grant to develop potential cure for Type 1 Diabetes

Orgenesis SPRL, a subsidiary of Orgenesis Inc., a leader in the emerging fields of cellular therapy and regenerative medicine, today announced that it has received the formal approval from the Walloon Region, Belgium (Service Public of Wallonia, DG06) for a €2.015 million support program for the research and development of a potential cure for Type 1 Diabetes.

26 Nov 2014

Leeds researchers identify gene associated with autism symptoms

Researchers at the University of Leeds have shed light on a gene mutation linked to autistic traits. The team already knew that some people with autism were deficient in a gene called neurexin-II.

26 Nov 2014

Research findings highlight power of expectations to drive brain activity in Parkinson's patients

Learning-related brain activity in Parkinson's patients improves as much in response to a placebo treatment as to real medication, according to a new study by researchers at the University of Colorado Boulder and Columbia University.

26 Nov 2014

TFAH applauds FDA for releasing new nutritional labeling rules

Trust for America's Health applauds the U.S. Food and Drug Administration for releasing two final rules establishing nutritional labeling requirements for menu items sold in retail food establishments and in vending machines.

26 Nov 2014

New hybrid vehicle to improve delivery of DNA vaccines is under development

Described recently in the Proceedings of the National Academy of Sciences, the technology is a biomedical advancement that could help unleash the potential of DNA vaccines, which despite two decades of research, have yet to make a significant impact in the treatment of major illnesses.

26 Nov 2014

Study reveals how one type of DNA damage may lead to several human diseases

Using a new imaging technique, National Institutes of Health researchers have found that the biological machinery that builds DNA can insert molecules into the DNA strand that are damaged as a result of environmental exposures. These damaged molecules trigger cell death that produces some human diseases, according to the researchers.

26 Nov 2014

SNTF protein can predict severity of post-concussion symptoms in professional athletes

New Penn Medicine research has found that elevated levels in the blood of the brain-enriched protein calpain-cleaved αII-spectrin N-terminal fragment, known as SNTF, shortly after sports-related concussion can predict the severity of post-concussion symptoms in professional athletes.

26 Nov 2014

FDA-approved therapy could be effective in older, African American patients with lung cancer

University of Cincinnati researchers have found in a phase-2 clinical trial that a Food and Drug Administration-approved therapy could be effective in treating both older and African American patients with advanced lung cancer who may not be candidates for chemotherapy.

26 Nov 2014

Experimental anti-cancer drugs PF-04691502 and PD-0325901 excel against colorectal cancer models

Genes make proteins and proteins tell your body's cells what to do: one talks to the next, which talks to the next, and to the next. Like a game of telephone, researchers call these "signaling pathways". Abnormalities in these signaling pathways can cause the growth and survival of cancer cells. Commonly, mutations or rearrangements of genes in the MAPK signaling pathway create cancer's fast growth, and alterations in the PI3K signaling pathway allow cancer cells to survive into virtual immortality.

26 Nov 2014

Janssen submits YONDELIS NDA for treatment of advanced soft tissue sarcoma

PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.

26 Nov 2014

Research sheds light on gene mutation linked to autistic traits

Researchers at the University of Leeds have shed light on a gene mutation linked to autistic traits.

25 Nov 2014

New Drexel study sheds light on the role of socioeconomic environment on diabetes risk

As the linked epidemics of obesity and diabetes continue to escalate, a staggering one in five U.S. adults is projected to have diabetes by 2050.

25 Nov 2014

Researchers discover two common genetic variants associated with memory performance

In the largest study of the genetics of memory ever undertaken, an international researcher team including scientists from Boston University School of Medicine, have discovered two common genetic variants that are believed to be associated with memory performance.

25 Nov 2014

Medical Condition News

Scientists make breakthrough in developing new treatment for advanced bladder cancer

Researchers set up innovative project to monitor physical activity of patients with haemophilia

BWH researchers identify two-faced role of TIM-3 protein

National Spine & Pain Centers opens new pain management center in Cumberland, Maryland

Researchers demonstrate efficacy of Bozepinib drug against cancerogenic stem cells

Quarter of all obesity-related cancers in 2012 attributed to increasing BMI, say researchers

Presence of certain proteins in HDL can lead to cardiovascular risk

Orgenesis receives €2.015 million grant to develop potential cure for Type 1 Diabetes

Leeds researchers identify gene associated with autism symptoms

Research findings highlight power of expectations to drive brain activity in Parkinson's patients

TFAH applauds FDA for releasing new nutritional labeling rules

New hybrid vehicle to improve delivery of DNA vaccines is under development

Study reveals how one type of DNA damage may lead to several human diseases

SNTF protein can predict severity of post-concussion symptoms in professional athletes

FDA-approved therapy could be effective in older, African American patients with lung cancer

Experimental anti-cancer drugs PF-04691502 and PD-0325901 excel against colorectal cancer models

Janssen submits YONDELIS NDA for treatment of advanced soft tissue sarcoma

Research sheds light on gene mutation linked to autistic traits

New Drexel study sheds light on the role of socioeconomic environment on diabetes risk

Researchers discover two common genetic variants associated with memory performance

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News